9th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Februrary 24-28 2002

10 April 2002. Related: Conference reports, Conference index, CROI 9 (Retrovirus) 2002.

Reports from the conference.

• Study results shed light on cardiovascular risks: role of antiretrovirals and metabolism of lipids and sugars

• Switch to abacavir improves lipoatrophy

• Potential use of niacin to reduce intra-abdominal fat

• Further benefits shown with New-Fill for facial atrophy

• Lipodystrophy associated with lower CD4+ T cell counts

• Treatment interruptions

• Analysis of cells from long term non-progressors points the way to using vaccines and STIs to restore immune response to HIV

• Symposium on T cell turnover and thymic function

• New drugs: perhaps some genuine excitement this time

• T20 and beyond: inhibition of HIV attachment and fusion at the 9th CROI

• Pharmacogenetics predict abacavir hypersensitivity

• Pregnancy: growing body of evidence supports treating maternal disease

• Peripheral neuropathy update